| Literature DB >> 34069610 |
Muhammad Faisal1,2, Peter D Berend3, Rudolf Seemann1, Stefan Janik3, Stefan Grasl3, Andrea Ritzengruber4, Herbert Mendel5, Arif Jamshed2, Raza Hussain2, Boban M Erovic1.
Abstract
(1) Background: Negative pressure wound therapy (NPWT) has been effectively used for wound management in comparison to traditional dressings. The purpose of this study was to provide an evidence-based review of NPWT in head and neck cancer patients, as well as the impact of previous irradiation and other risk factors on wound healing. (2) Material andEntities:
Keywords: head and neck cancers; negative pressure wound therapy; radiation therapy
Year: 2021 PMID: 34069610 PMCID: PMC8160636 DOI: 10.3390/cancers13102482
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639
Figure 1The flow diagram was adapted from PRISMA recommendations.
Demographics of the cohort, wound response, healing time, pressure dynamics, comorbidities, risk factors, and complications.
| Author | Study Type | Year of | N | Age (in Years) | M:F | Pressure | Negative Pressure | Comorbidity | Previous Irradiation | Healing Response | Complication |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Andrew [ | 2006 | Retrospective case series | 12 | 67 | 8:4 | - | 125 | DM *-2 | 1 | 100 | - |
| Andrew [ | 2008 | Case series | 3 | 67 | 2:1 | - | 150 | 2 | 66 | ||
| Asher [ | 2014 | Retrospective cohort | 108 | 64 | 87:28 | Continuous | 125 | - | 47 | 75 | Bleeding |
| Asher [ | 2014 | Retrospective cohort | 12 | 63 | 6:7 | Continuous | 125 | DM *-4 | 9 | 92 | - |
| Dhir [ | 2009 | Retrospective cohort | 19 | 63 | 17:2 | Continuous | 110 | DM *-8 | 10 | 84 | - |
| Dorneden [ | 2019 | Case series | 3 | 66 | 1:2 | Continuous | 125 | - | 0 | 100 | Electrolyte loss |
| Inatomi [ | 2019 | Retrospective cohort | 32 | 63 | 28:6 | - | 125 | - | 14 | 82 | None |
| Lin [ | 2018 | Retrospective series | 31 | 52 | 29:2 | - | 100 | DM *-5 | 0 | 90 | - |
| Reiter [ | 2013 | Retrospective cohort | 23 | 58 | 12:0 | Continuous | 125 | HTN *-3 | 11 | 78 | None |
| Rosenthal [ | 2005 | Retrospective series | 14 | 59 | 14:5 | Continuous | 125 | - | 0 | 86 | None |
| Satteson [ | 2015 | Retrospective cohort | 69 | 66 | 45:25 | Continuous | - | Smoking-30 | 36 | 90 | Infection |
| Tian [ | 2016 | Case series | 4 | 55 | 3:1 | - | - | - | 0 | - | None |
| Thierauf [ | 2018 | Retrospective case series | 20 | 8:5 | 70 | DM *-3 | 7 | 110 | None | ||
| Umezawa [ | 2018 | Case series | 17 | 67 | 10:1 | - | 6 | 100 | Contact dermatitis | ||
| Yang [ | 2013 | Case series | 13 | 50 | 13:0 | Continuous | 125 | DM *-4 | 0 | 92 | None |
* Abbreviations: N: number; M: male; F: female; diabetes mellitus; CAD: coronary artery disease; HTN: hypertension; RA: rheumatoid arthritis; HIV: human immunodeficiency syndrome; CVA: cerebrovascular accident; PVD: peripheral vascular disease.
Figure 2The mean healing response using NPWT therapy in the absence of previous irradiation was found to be 92.40 ± 8.29, compared to 86.7 ± 11.7 with previous irradiation. Abbreviation: RT: radiotherapy; NRT: no radiotherapy; NPWT: negative pressure wound therapy.
Univariate and multivariate binary regression analysis to assess wound healing response in the presence of risk factors.
| Variable | Univariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|---|
| OR |
| 95% CI | OR |
| 95% CI | |
| Sex (Female) | 2.26 | 0.103 | 0.85–6.0 | 2.01 | 0.223 | 0.66–6.15 |
| RT (Yes) | 4.34 | 0.005 | 1.54–11.6 | 4.07 | 0.010 | 1.39–11.9 |
| DM (Yes) | 5.65 | <0.001 | 2.14–14.9 | 5.62 | 0.001 | 2.01–15.6 |
| RT and DM (Yes) * | 10.6 | <0.001 | 3.38–33.3 | |||
| Malnutrition (Yes) | 1.34 | 0.671 | 0.35–5.21 | |||
| PVD (Yes) | 1.17 | 0.889 | 0.13–10.2 | |||
| Hypothyroidism (Yes) | 0.86 | 0.889 | 0.10–7.52 | |||
* Abbreviations: RT: radiotherapy; DM: diabetes mellitus; PVD: peripheral vascular disease; OR: odds ratio; CI: confidence interval.
Results of quality of assessment using National Institutes of Health Quality Assessment Tools [23].
| Authors | Study Design | Clear Study Objective | Sample Size Justification | Association/Assessed Levels of Exposure on Outcome | Exposure Defined/Exposure Assessed Repeatedly | Clearly Define Outcome | Clearly Statistic Defined | Follow Up | Confounding Variables Measured | Rating |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrew [ | Retrospective case series | +/+ | + | +/+/+ | +/+ | + | + | + | NR * | Good |
| Andrew [ | Case series | +/+ | NR * | + | +/+ | CD * | + | + | NR * | Fair |
| Asher [ | Retrospective cohort | +/+ | + | +/+/+ | +/+ | + | + | + | + | Good |
| Asher [ | Retrospective cohort | +/+ | + | +/+/+ | +/+ | + | + | + | + | Good |
| Dhir [ | Retrospective cohort | +/+ | + | +/+/+ | +/+ | + | + | + | + | Good |
| Dorneden [ | Case series | + | CD * | +/+/+ | +/+ | CD * | + | + | NR * | Fair |
| Inatomi [ | Retrospective cohort | +/+ | + | +/+/+ | +/+ | + | + | + | + | Good |
| Lin [ | Retrospective series | +/+ | + | +/+/+ | + | + | + | + | CD * | Good |
| Reiter [ | Retrospective cohort | +/+ | + | +/+/+ | + | + | + | + | + | Good |
| Rosenthal [ | Retrospective series | +/+ | + | +/+/+ | + | + | + | + | + | Good |
| Satteson [ | Retrospective cohort | +/+ | + | +/+/+ | + | + | + | + | + | Good |
| Tian [ | Case series | + | CD * | + | + | + | + | + | NR * | Fair |
| Thierauf [ | Retrospective case series | + | + | + | + | + | + | + | + | Good |
| Umezawa [ | Case series | + | + | +/+ | + | + | + | + | CD * | Good |
| Yang [ | Case series | + | + | +/+/+ | + | + | + | + | + | Good |
* Abbreviations: CD: cannot determine; +: criterion met; NR: not recorded.
Figure 3(a) Pectoralis major muscle flap coverage for reconstruction plate that developed hematoma and infection; (b) evacuation of hematoma and debridement; (c) the placement of a hydrocolloid film around the wound margins and a grid to protect the thoracodorsal vessels of the flap; (d) the placement of a polyurethane foam dressing with an open pore structure; (e) good blood flow and granulation tissue formation after 1st dressing; (f) uniform healing at 2nd dressing; (g) wound healing at 3rd week; and (h) wound healing after 4 months.
Figure 4(a) Exposure of reconstruction plate post irradiation, (b) wound debridement and marking of advancement rotation flap, and (c) raising the flap; (d) adequacy of flap for plate coverage, (e) local infection resulting in flap dehiscence and plate exposure again, and (f) no wound coverage despite using NPWT.